Objective: The goal of this study was to determine if the concentrations of a set of 8 angiogenic molecules (plateletderived growth factor-BB (PDGF-BB), vascular endothelial growth factor, basic fibroblast growth factor, angiogenin, keratinocyte growth factor (KGF), tissue inhibitor of metalloproteinases-1 (TIMP-1), intercellular adhesion molecule-1, angiopoietin-2) in serum can be used as a noninvasive diagnostic test for prostate pathology in addition to use of the prostate specific antigen value, abnormal digital rectal examination, and pathological confirmation. Materials and Methods: Sera from 40 patients without cancer (control group), with prostate cancer, with benign prostatic hyperplasia, or with chronic prostatitis were used for FAST Quant® (Whatman) analysis. Results: The Shapiro-Wilk test was used for testing the normality of distribution. Angiopoietin-2, KGF, PDGF-BB, and TIMP-1 showed normal distributions (p > 0.05). Our results showed that there are significant serum concentration differences between prostate cancer, benign prostatic hyperplasia, chronic prostatitis, and the control group for the angiogenic molecules KGF, angiopoietin-2, PDGF-BB, and TIMP-1. Conclusion: Our data suggest that FAST Quant® (Whatman) analysis of multiple serum biomarkers consisting of angiogenesis molecules can improve the diagnosis of prostate pathology in a noninvasive manner.